Elite Pharmaceuticals Inc (ELTP)

[kayak_wench]

Think about it. We have $70 million in revenue with current product market. A share price of $0.4 and a P/E of 20ish. Our potential revenue will at least double with approved products alone . This means once we start making those sales assiming a P/E of 20 share price will be about $0.8 That is with all approved products on market having market value of about $2 billion

Now add in Vyvanse launch. If we get 10% of a $3billion market that should push share price to at least $1.2 assume conservative PE of 10. But I don’t think the P/E will be 10 because we know we have more billion dollar products in the pipeline e. Nudge the P/E to 15 and you have the $1.80. If it stays at the current 20 we are in the $2 range

This is the math explaining what is happening. I don’t think we going to get another article because the people who would write it are buying. The won’t promote it until price reflects market value. I think our holding sound 40 with maybe a pop to 50 cents before coming back down to 40 cents is reasonable. But when we get Vyvanse approval in Nov, stand back for the second stage burners engaging. If we also get the BE results for the third needle mover CNS there will be yet another move up.

Frankly it’s a bit overwhelming to think about.